Previous reports have shown that the development of thyroid dysfunction was significantly associated with positive Tg Ab and/or TPO Ab before ICI therapy in patients with NSCLC, melanoma, and renal cell carcinoma.2 This evidence concerns the gene TPO and hereditary clear cell renal cell carcinoma.